People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elevation Pharmaceuticals Inc | — | Biotechnology | Series A | $27.4M | $448.3M | 2010 |
Jan K. Leschly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jan K. Leschly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam L. Garner | 1 | 11 |
| Brenton K. Ahrens | 1 | 3 |
| William M. Gerhart | 1 | 2 |
| Jaisim K. Shah | 1 | 1 |
| Pravin K. Soni, Ph.D. | 1 | 1 |
| Heather K. Preston, M.D. | 1 | 1 |
| Ahmet K. Tutuncu, M.D., Ph.D. | 1 | 1 |
| Heath K. Lukatch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.